Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.1K
Overview
32.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glyco-Ligated Binders to Lectins: Multivalency vs Specificity.

The journal of physical chemistry. B·2026
Same author

Anomalous ultrafast lithium-ion transport through boron nitride nanotube membranes.

Nature nanotechnology·2026
Same author

Ligand Dissociation Pathways from Membrane Receptors Revealed by Weighted Ensemble Simulations.

The journal of physical chemistry. B·2025
Same author

On-the-Fly Sequential Design of Simple Peptides.

Journal of chemical information and modeling·2025
Same author

Atomistic mechanisms of the regulation of small-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel (SK2) by PIP2.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Sulfoglycodendron Antivirals with Scalable Architectures and Activities.

Journal of chemical information and modeling·2024

Related Experiment Video

Updated: Nov 19, 2025

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
07:44

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

3.4K

Retrained Generic Antibodies Can Recognize SARS-CoV-2.

Yanxiao Han1, Katherine D McReynolds2, Petr Král1,3

  • 1Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois 60607, United States.

The Journal of Physical Chemistry Letters
|February 1, 2021
PubMed
Summary

Novel peptide boosters can retrain existing Hepatitis B antibodies to recognize SARS-CoV-2, offering a rapid and affordable strategy for neutralizing emerging viruses and mitigating pandemics.

More Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.0K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

1.0K

Related Experiment Videos

Last Updated: Nov 19, 2025

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
07:44

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

3.4K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.0K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

1.0K

Area of Science:

  • Virology
  • Immunology
  • Biotechnology
  • Computational Chemistry

Background:

  • Emerging viral threats like SARS-CoV-2 pose significant public health challenges.
  • Rapid mitigation strategies are crucial during the early stages of infection.
  • Leveraging existing immune components offers a potential avenue for broad-spectrum antiviral defense.

Purpose of the Study:

  • To computationally design peptide-based boosters capable of redirecting Hepatitis B antibodies towards SARS-CoV-2.
  • To investigate the binding specificity and stability of these boosters with viral targets and antibodies.

Main Methods:

  • Computational design of double-faced peptide boosters.
  • Inclusion of ACE2-mimic peptides to target the SARS-CoV-2 receptor binding domain (RBD).
  • Inclusion of Hepatitis B core-antigen to target Hepatitis B antibody fragments.
  • Molecular dynamics simulations to assess binding interactions.

Main Results:

  • Designed boosters demonstrated highly specific binding to the SARS-CoV-2 RBD.
  • Boosters exhibited stable binding to Hepatitis B antibody fragments.
  • The dual-targeting nature of the boosters was confirmed through simulations.

Conclusions:

  • Peptide-based boosters can effectively retrain existing antibodies for recognition of novel viruses.
  • This approach offers a potentially cost-effective and rapid method for neutralizing emerging viral pathogens.
  • The strategy holds promise for future pandemic preparedness and response.